RNA Interference: Mechanisms, Technical Challenges, and Therapeutic Opportunities

Methods in Molecular Biology

Volumn 1218, Issue , 2015, Pages

  Sioud, Mouldy ^a  

^a NONE

Author keywords

Clinical trials; Delivery materials; Functional siRNAs; RNAi; siRNA

Indexed keywords

DOUBLE STRANDED RNA; LIPID; LOCKED NUCLEIC ACID; PLASMA PROTEIN; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; ARGONAUTE PROTEIN; CARBOXYPEPTIDASE; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; DROSHA PROTEIN, HUMAN; DRUG CARRIER; EIF2C2 PROTEIN, HUMAN; MESSENGER RNA; RIBONUCLEASE III; SCPEP1 PROTEIN, HUMAN;

ALLERGIC REACTION; ARTICLE; BASE PAIRING; CELL MIGRATION; CHEMICAL MODIFICATION; ENDOSOME; EXOSOME; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CLINICAL TRIAL (TOPIC); GENETICS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ARGONAUTE PROTEINS; BIOLOGICAL TRANSPORT; CARBOXYPEPTIDASES; CLINICAL TRIALS AS TOPIC; DEAD-BOX RNA HELICASES; DRUG CARRIERS; EXOSOMES; HUMANS; LIVER NEOPLASMS; RIBONUCLEASE III; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84955418802     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1538-5_1     Document Type: Article

References (56)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specifi c genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806–811.
2. Hamilton AJ, Baulcombe DC (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286:950–952.
3. Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25–33.
4. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498.
5. Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM (2003) Structure and conserved RNA binding of the PAZ domain. Nature 426:468–474.
6. Pencheva N, Tavazoie SF (2013) Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15:546–554.
7. Zamore PD, Haley B (2005) Ribogenome: the big word of small RNAs. Science 309: 1519–1524.
8. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376–385.
9. Liu Q, Rand TA, Kalidas S, Du F, Kim HE, Smith DP, Wang X (2003) R2d2, a bridge between the initiation and effector steps of the drosophila RNAi pathway. Science 301: 1921–1925.
10. Liu X, Jiang F, Kalidas S, Smith D, Liu Q (2006) Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes. RNA 12:1514–1520.
11. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2- containing RNAi enzyme complexes. Cell 123: 607–620.
12. Wee LM, Flores-Jasso CF, Salomon WE, Zamore PD (2012) Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell 151:1055–1067.
13. Holen T, Amarzguiouni M, Wiiger MT, Babaie E, Prydz H (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757–1766.
14. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD (2004) A protein sensor for siRNA asymmetry. Science 306:1377–1380.
15. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N et al (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208
16. Reyolds A, Leake D, Boese Q, Scaringe S, Marchall WS et al (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326–330.
17. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H et al (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 32:936–948.
18. Sano M, Sierant M, Miyagishi M, Nakanishi M, Takagi Y, Sutou S (2008) Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection. Nucleic Acids Res 36:5812–5821.
19. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, Johnson JM, Lim L, Karpilow J, Nichols K, Marshall W, Khvorova A, Linsley PS (2006) Position-specifi c chemical modifi cation of siRNAs reduces “off-target” transcript silencing. RNA 12:1197–1205.
20. Paul CP, Good PD, Winer I et al (2002) Effective expression of small interference RNA in human cells. Nat Biotechnol 20:505–508.
21. Watts JK, Deleavey GF, Damha MJ (2008) Chemically modifi ed siRNA: tools and applications. Drug Discov Today 13:842–855.
22. Hoerter JA, Walter NG (2007) Chemical modifi cation resolves the asymmetry of siRNA strand degradation in human blood serum. RNA 13:1887–1893.
23. Mook OR, Baas F, de Wissel MB, Fluiter K (2007) Evaluation of locked nucleic acidmodifi ed small interfering RNA in vitro and in vivo. Mol Cancer Ther 6:833–843.
24. Laursen MB, Pakula MM, Gao S, Fluiter K, Mook OR, Baas F et al (2010) Utilisation of unlocked nucleic acid to enhance siRNA performance in vitro and in vivo. Mol Biosyst 6:862–870.
25. Sioud M (2006) Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur J Immunol 36:1222–1230.
26. Rettig GR, Behlke MA (2012) Progress toward in vivo use of siRNAs-ii. Mol Ther 20:483–512.
27. Tammali R, Reddy AB, Saxena A, Rychahou PG, Evers BM, Qiu S, Awasthi S, Ramana KV, Srivastava SK (2011) Inhibition of aldose reductase prevents colon cancer metastasis. Carcinogenesis 32:1259–1267.
28. Huang Y et al (2011) Elimination pathways of systemically delivered siRNA. Mol Ther 19: 381–385.
29. Barton GM, Medzhitov R (2002) Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci U S A 99:14943–14945.
30. Winston WM, Molodowitch C, Hunter CP (2002) Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science 295:2456–2459.
31. Saleh MC, Van Rij RP, Hekele A, Gillis A, Foley E, O’Farrell PH, Andino R (2006) The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat Cell Biol 8:793–802.
32. Feinberg EH, Hunter CP (2003) Transport of dsRNA into cells by the transmembrane protein SID-1. Science 301:1545–1547.
33. Fougerolles AD, Vornlocher HP, Maraganore J et al (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6:443–453.
34. Kanastry R, Dorkin JR, Vegas A, Anderson D (2013) Delivery siRNA therapeutics. Nat Mater 12:967–977.
35. Simoes S, Filipe A, Faneca H, Mano M, Penacho N, Duzgunes N, De Lima MP (2005) Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2:237–254.
36. Sun TM, Du JZ, Yan LF et al (2008) Selfassembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials 29:4348–4355.
37. Peer D, Karp JM, Hong S et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760.
38. Gomes-Da-Silva LC, Fonseca NA, Moura V, Pedroso De Lima MC, Simoes S, Moreira JN (2012) Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Acc Chem Res 45:1163–1171.
39. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, Vaish N, Zinnen S, Vargeese C, Bowman K, Shaffer CS, Jeffs LB, Judge A, Maclachlan I, Polisky B (2005) Potent and persistent in vivo anti-HBV activity of chemically modifi ed siRNAs. Nat Biotechnol 23:1002–1007.
40. Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN et al (2006) RNAi-mediated gene silencing in non-human primates. Nature 441:111–114.
41. Judge AD, Robbins M, Tavakoli I, Levi J, Hu L, Fronda A, Ambegia E, Mcclintock K, Maclachlan I (2009) Confi rming the RNAimediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Invest 119:661–673.
42. Zhang Y, Zhang YF, Bryant J, Charles A, Boado RJ, Pardridge WM (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptorprolongs survival in intracranial brain cancer. Clin Cancer Res 10:3667–3677.
43. Wolfrum C, Shi S, Jayaprakash KN et al (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 25: 1149–1157.
44. Lundberg M, Wikstrom S, Johansson M (2003) Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 8:143–150.
45. Oishi M, Nagasaki Y, Itaka K et al (2005) Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile β-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 127: 1624–1625.
46. Behr J-P (1997) The proton sponge: a trick to enter cells the viruses did not exploit. CHIMIA 51:34–36.
47. Stevenson M, Ramos-Perez V, Singh S et al (2008) Delivery of siRNA mediated by histidine- containing reducible polycations. J Control Release 130:46–56.
48. Leng Q, Scaria P, Lu P et al (2008) Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts. Cancer Gene Ther 15:485–495.
49. Kumar VV, Pichon C, Refregiers M et al (2003) Single histidine residue in head-group region is suffi cient to impart remarkable gene transfection properties to cationic lipids: evidence for histidine mediated membrane fusion at acidic pH. Gene Ther 10:1206–1215.
50. Takae S, Miyata K, Oba M et al (2008) PEGdetachable polyplex micelles based on disulfi delinked block catiomers as bioresponsive nonviral gene vectors. J Am Chem Soc 130: 6001–6009.
51. Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C et al (2013) Effi ciency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol 31: 653–658.
52. Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U et al (2013) Imagebased analysis of lipid nanoparticle-mediated siRNA delivery, intracellular traffi cking and endosomal escape. Nat Biotechnol 31: 638–646.
53. Pan BT, Johnstone RM (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:967–978.
54. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659.
55. Van Den Boorn JG, Schlee M, Coch C, Hartmann G (2011) SiRNA delivery with exosome nanoparticles. Nat Biotechnol 29: 325–326.
56. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–345.